RT Journal Article
SR Electronic
A1 Hand, Larry
T1 Ranolazine Provides Benefit over Placebo for T2DM Patients with Angina
JF MD Conference Express
YR 2013
FD SAGE Publications
VO 13
IS 2
SP 21
OP 22
DO 10.1177/155989771302013
UL http://mdc.sagepub.com/content/13/2/21.abstract
AB In a trial focused on the treatment of stable angina in patients with type 2 diabetes, ranolazine significantly reduced the frequency of angina episodes compared with placebo. This article presents the results of the Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina study [TERISA; Kosiborod M et al. J Am Coll Cardiol 2013].